Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Clorox
CLX
$13.1B
| $147M | 0.2% |
1,049,897
+193,567
| +23% | +$27.5M |
|
102
Union Pacific
UNP
$174B
| $147M | 0.2% |
709,759
+218,160
| +44% | +$44.7M |
|
103
Hilton Worldwide
HLT
$70.8B
| $147M | 0.2% |
1,160,238
+709,638
| +157% | +$93.5M |
|
|
K
104
DELISTED
Kellanova
K
| $146M | 0.2% |
2,185,752
-245,016
| -10% | -$16.6M |
|
105
Allison Transmission
ALSN
$10.3B
| $145M | 0.2% |
3,479,319
+80,600
| +2% | +$3.31M |
|
106
PACCAR
PCAR
$69.8B
| $144M | 0.2% |
2,183,817
+972,150
| +80% | +$63.5M |
|
107
Baidu
BIDU
$35.9B
| $143M | 0.2% |
1,246,699
-51,600
| -4% | -$5.27M |
|
108
Carrier Global
CARR
$52.4B
| $142M | 0.19% |
3,453,231
-1,520,300
| -31% | -$61.7M |
|
109
Marriott International
MAR
$91.1B
| $140M | 0.19% |
943,462
+662,346
| +236% | +$102M |
|
110
Regeneron Pharmaceuticals
REGN
$82.1B
| $138M | 0.19% |
191,441
-16,959
| -8% | -$12.5M |
|
111
Hormel Foods
HRL
$13.4B
| $138M | 0.19% |
3,031,963
+690,900
| +30% | +$32.2M |
|
112
Pinterest
PINS
$13.4B
| $137M | 0.19% |
5,656,255
-3,845,020
| -40% | -$91.7M |
|
113
Flowers Foods
FLO
$1.52B
| $137M | 0.19% |
4,769,303
-611,282
| -11% | -$17.2M |
|
114
Medtronic
MDT
$116B
| $136M | 0.19% |
1,750,941
-1,125,400
| -39% | -$91.2M |
|
115
TransDigm Group
TDG
$68.7B
| $135M | 0.18% |
214,400
-7,900
| -4% | -$4.65M |
|
116
New Oriental
EDU
$8.84B
| $132M | 0.18% |
3,798,454
-318,292
| -8% | -$8.99M |
|
117
Altria Group
MO
$109B
| $131M | 0.18% |
2,863,944
-947,811
| -25% | -$42.9M |
|
118
Datadog
DDOG
$88.6B
| $130M | 0.18% |
1,765,266
+197,266
| +13% | +$15.4M |
|
119
Chubb
CB
$134B
| $125M | 0.17% |
567,999
-275,000
| -33% | -$57.2M |
|
120
Blackstone
BX
$118B
| $122M | 0.17% |
1,644,600
+700,200
| +74% | +$60.5M |
|
121
Coinbase
COIN
$39.2B
| $121M | 0.17% |
3,424,122
+482,122
| +16% | +$25.4M |
|
122
J.M. Smucker
SJM
$12.5B
| $121M | 0.17% |
762,576
-69,000
| -8% | -$10.3M |
|
123
Sysco
SYY
$40.3B
| $121M | 0.16% |
1,576,200
+201,700
| +15% | +$16.3M |
|
124
Tyson Foods
TSN
$19.9B
| $118M | 0.16% |
1,903,500
+696,100
| +58% | +$45.3M |
|
125
American Airlines Group
AAL
$10.1B
| $118M | 0.16% |
9,251,400
-58,800
| -0.6% | -$797K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.